- Pharma
- 1 min read
FDA probe of Abbott facility finds quality control issues
Complaints that the facility's products had caused bacterial infections forced Abbott to recall certain Alimentum, Similac and EleCare baby formulas last month, prompting a probe from the U.S. Food and Drug Administration (FDA).
Complaints that the facility's products had caused bacterial infections forced Abbott to recall certain Alimentum, Similac and EleCare baby formulas last month, prompting a probe from the U.S. Food and Drug Administration (FDA).
The inspection from Jan. 31 to March 18 showed https://www.fda.gov/media/157073/download?utm_medium=email&utm_source=govdelivery that Abbott did not have a control system covering all stages of processing to prevent microbe contamination of infant formula.
Personnel working with infant formula also did not wear necessary protective apparel, the FDA said.
"We're taking this very seriously and are working closely with the FDA to implement corrective actions," Abbott said in a statement.
No Cronobacter sakazakii was found during the company's testing of products that were distributed to consumers, Abbott added.
The company also said that the genetic makeup of the Cronobacter sakazakii found at the Michigan plant did not match that of the reported cases.
Cronobacter sakazakii bacteria can cause serious invasive infections and premature infant death.
COMMENTS
All Comments
By commenting, you agree to the Prohibited Content Policy
PostBy commenting, you agree to the Prohibited Content Policy
PostFind this Comment Offensive?
Choose your reason below and click on the submit button. This will alert our moderators to take actions